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Introduction
Antibiotics are among the most commonly prescribed 
medications in hospital settings yet inappropriate utili-
zation frequently occurs (1). Antibiotic misuse is associat-
ed with increased mortality, morbidity, length of hospital 
stay, cost of healthcare, and most importantly antibiotic 
resistance (1). Antimicrobial Stewardship refers to a set 
of coordinated interventions intended to optimize the 
use of antimicrobials in various settings including out-
patient clinics and inpatient healthcare settings (2,3). In 
fact, the proper use of antibiotics leads to enhancing drug 
and patient safety, reducing drug consumption and cost 
containment, limiting the emergence of resistant organ-
isms, with an end goal of improving patient outcomes 
(4). Antimicrobial stewardship programmes (ASPs) are 
designed to ensure appropriate selection of an effec-
tive antimicrobial drug regimen, dose, time, duration 
of therapy, and route of administration (5). An effective 
programme is one that is led by a coalition of physicians, 
clinical pharmacists and other healthcare members, and 
is committed to leadership where necessary humanistic, 
financial, information technology, and time resources are 
implemented (6–9).
Several antimicrobial stewardship strategies have 
been previously evaluated in hospital settings such as 
streamlining, prospective audit with feedback, formulary 
restriction and preauthorization, amongst others (4,5). 
Such interventions can be only successful if they meet the 
specific needs of the healthcare institution with dedicated 
work between healthcare professionals, administrators, 
information technology personnel, and policy-makers 
(2,10). Point prevalence studies (PPSs) serve as audit 
markers and practical surveillance tools to monitor 
antibiotic prescribing patterns over time (11). They tend 
to assess antibiotic use across and within healthcare 
settings, identify targets for quality enhancement, and 
track differences in practices between institutions (12). 
Moreover, monitoring antibiotic use and prescribing and 
identifying resistance patterns is crucial in identifying 
opportunities for improvement, and strategies to 
overcome barriers associated with antibiotic misuse (13). 
In addition, regular reporting of information on antibiotic 
use and outcome results to multidisciplinary teams 
serves as a key element of successful ASPs (13). In fact, 
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education and ongoing training opportunities should be 
readily available for healthcare professionals with an aim 
to promote effective antibiotic prescribing (14).
Patients diagnosed with cancer, in particular with 
hematologic malignancies and neutropenia, tend to 
be more vulnerable to acquiring infections such as 
Clostridium difficile infection (CDI), bloodstream and 
other organ infections caused by multi-drug resistant 
organisms (MDROs) (15,16). Thus, antibiotics are often 
prescribed for both treatment and prophylaxis. In fact, 
appropriate antibiotic selection, rationale behind the use 
of antibiotics, and proper adherence to a successful ASP 
in such population was associated with lower mortality 
rates (17). A previous PPS conducted by Hammuda et 
al. in Qatar at the National Center for Cancer Care and 
Research (NCCCR) showed that only 57.6% of antibiotic 
prescriptions met national treatment guidelines or 
followed local antibiotic prescribing policies (18). Since 
the time of that study conduction, local guidelines have 
been updated and the institution has introduced an ASP 
led by a physician and a dedicated clinical pharmacist. 
However, no systematic evaluation of this service has 
occurred to date as well as any impact of educational 
interventions on clinical practice.
This study targets four objectives; primarily, we aimed 
to evaluate antibiotic prescribing in cancer patients by 
assessing compliance with local prescribing guidelines 
over multiple time points by performing baseline PPSs. 
This was followed by a prospective audit to characterize 
and assess antibiotic interventions during the patient’s 
follow-up period by tracking the prescribing and 
resistance patterns based on culture results. Secondly, 
we aimed to educate the multidisciplinary team of 
our findings and provide feedback using the “Plan, Do, 
Study, Act” (PDSA) quality improvement tool adopted 
from the Institute of Healthcare Improvement. Thirdly, 
we intended to evaluate the impact of the educational 
intervention on AMS by repeating a second antibiotic 
audit. Lastly, we aimed to identify facilitators and barriers 
to ASP implementation in Qatar through interviews with 
pharmacists who witnessed the educational intervention.
Data sources and methods
Phase 1: Baseline PPSs with prospective follow 
up on antibiotic therapy
Six cross-sectional audits of antibiotic prescribing were 
conducted at NCCCR in Qatar. NCCCR is a 65-bed tertiary 
care teaching hospital that admits oncology/haematolo-
gy, palliative care, and bone marrow transplant patients. 
The PPSs were performed on six separate days over an 
11-day period between February 14 and February 24, 
2016. Six PPSs were conducted to account for variations 
in weekly prescribing, as well as prescriber dependent 
prescribing; as consulting physicians typically rotate on 
a weekly basis. The audits were conducted on a Sunday, 
Monday, and Wednesday of each of the two weeks. All 
data was collected from electronic healthcare records at 
NCCCR. This hospital documents all patient information 
using CERNER® (Missouri MO, United States of Amer-
ica). Ethical approval was obtained from the Qatar Uni-
versity Institutional Review Board (QU-IRB 521-E/15), and 
Hamad Medical Corporation, Medical Research Center 
(15415/15).
All patients admitted on each study day were assessed 
for inclusion. Patients were included if they received 
at least one systemic antibacterial agent on the study 
day. Patients receiving antibiotics through outpatient 
intravenous programs were excluded. Patient receiving 
anti-tuberculosis, anti-fungal or anti-viral prescriptions 
were also excluded. On each day, all medical wards 
were audited using an adapted modified audit tool: 
2006 European Surveillance of Antibiotic Consumption 
Point Prevalence Survey (ESAC PPS) Audit Tool (19). Data 
was collected by three pharmacy students, a research 
collaborator, and the primary research investigator. 
A senior investigator verified all data. Data collected 
included: age, gender, antimicrobial agent (dose, route, 
frequency and duration); classified according to the World 
Health Organization’s anatomical therapeutic chemical 
(ATC) classification system (20), treatment indication, 
guideline compliance, and documentation of rationale 
if guidelines were not adhered to. Guideline compliance 
was determined using institutional antibiotic prescribing 
policies, which refer to preauthorized antibiotics policies, 
and are based on local antibiogram data; however, they 
are primarily in line with guidelines from the Infectious 
Diseases Society of America (IDSA) or other tertiary 
references (21,22).
The second part of phase 1 included a prospective 
observation and assessment of physicians’ prescribing 
behaviour during patient follow-up period, that applies to 
patients with length of hospital stay of at least 48 hours 
and have received two doses or more of an antibiotic on 
those days. Culture and sensitivity results were taken 
into account for these patients (bug/drug mismatch, 
escalation or streamlining of therapy). This was 
performed over 14 days as per our study protocol. Data 
was entered into the IBM® SPSS® Statistics V23.0 (New 
York NY, United States of America) software for analysis. 
Data was analyzed descriptively.
Phase 2: Feedback using an educational 
intervention
An educational intervention was performed to evaluate 
the results obtained from the first phase of our study; 
specifically, to address the gaps and areas for improve-
ment that were identified. The “Plan-Do-Study-Act” 
(PDSA) model was utilized which is a quality improve-
ment tool implemented by the Institution for Health Im-
provement with the goal of establishing a functional as-
sociation between process changes in healthcare systems 
and variations in outcomes (23,24). We performed an 
on-spot bed-side educational intervention during multi-
disciplinary rounds on the wards targeting all stakehold-
ers (each team consisted of a consultant, medical fellow, 
medical resident, clinical pharmacist and a nurse) within 
four medical teams (infectious diseases, oncology, he-
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matology/bone marrow transplantation, and palliative 
care) to inform them about the goal of the intervention 
and to gather feedback for future improvement. After 
implementation, the intervention was studied in terms 
of impact on practice. This methodology is adapted from 
a well-established PDSA model used for interventional 
techniques aiming to promote changing behaviors (23).
Phase 3: Impact of change
After the interventional period was complete, an audit of 
prescribing behaviours was repeated to assess the impact 
of change. The medical records were reviewed post the 
intervention on the same day of the intervention. The 
main outcome measure we looked at was to address the 
improvement of documentation in patients’ electronic 
healthcare records and to determine whether the inter-
vention did address the gaps identified on the same day of 
the educational intervention after the multidisciplinary 
rounds were over. The same statistical analysis approach 
in phase 1 of the study was used to interpret the results 
obtained. A PDSA worksheet adapted from the Institute 
for Healthcare Improvement was used to document a test 
of change (23).
Phase 4: Qualitative thematic analysis
In order to identify facilitators and barriers to effective im-
plementation of ASPs within Qatar, a qualitative research 
study was conducted that aimed to identify perceptions 
of pharmacists regarding stewardship principles, proce-
dures, and sustainability, in addition to evaluate the ef-
fectiveness of educational interventions on the enhance-
ment of AMS in the future. A pre-defined topic guide for 
the semi-structured interviews was developed. The guide 
included 10 open-ended questions. The interviewing pro-
cess took place at NCCCR. Every interview began with an 
engagement question followed by a series of exploratory 
questions and ended with an exit question. All interviews 
were recorded using a recording device and an informed 
consent was obtained prior to initiating the process. Each 
interview lasted between 20 and 30 minutes. Each inter-
view was transcribed verbatim which was reviewed by 
the primary research investigator for accuracy and com-
pleteness. Transcripts then underwent a content analysis 
using an inductive, open-coding approach (25).
Results
Phase 1: Prospective audit
Six-point prevalence studies
The mean age of patients whose medical records were 
audited was 47.2 years with a predominance of the male 
gender (70.5%). Table 1 shows the different types of infec-
tions for which an antibiotic was prescribed. The most 
common documented reason for prescribing antibiot-
ics was febrile neutropenia (20.7%) followed by bacter-
emia (14.7%). However, rationale for antibiotic use was 
1%
18%
21%
14%
12%
2%
5%
3%
1%
2%
9%
1%
11% Penicillins (1)
Cephalosporins (2)
Carbapenems (3)
B-actams/B-lactamase inhibitors (4)
Fluoroquinolones (5)
Aminoglycosides (6)
Tetracycline/Glycylcycline (7)
Macrolide (8)
Lincosamide (9)
Glycopeptide (10)
Nitroimidazole (11)
Nitrofurantoin
Sulfonamide (12)
Figure 1 Usage of antibiotics by classes
1: amoxicillin, ampicillin, penicillin; 2: cefazolin, cefuroxime, ceftriaxone, cefepime; 3: ertapenem, meropenem; 4: amoxicillin/
clavulanic acid, piperacillin/tazobactam; 5: ciprofloxacin, levofloxacin, lomefloxacin, moxifloxacin; 6: amikacin, gentamicin; 7: 
doxycycline/tigecycline; 8: azithromycin; 9: clindamycin; 10: vancomycin; 11: metronidazole; 12: trimethoprim/sulfamethoxazole
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not present in 15.2% of cases. The most frequently used 
class of antibacterial agents was carbapenems (21.4%), 
then cephalosporins (18.2%), followed by beta-lactam/be-
ta-lactamase inhibitor combinations (14.1%). Frequencies 
of prescribed antibacterial agents per day throughout the 
total 6 days are outlined in Figure 1. The majority of anti-
biotics were given via the intravenous route (58.4%). The 
majority of prescriptions complied with local prescribing 
guidelines (59.5%). The rationale behind choosing not to 
adhere to clinical practice guidelines was not document-
ed in 37.2% of the cases.
Prospective follow-up
Follow-up data were collected as a secondary objective to 
determine the appropriateness of antibiotic utilization 
during the hospital stay in patients who stayed at least 
two days in the hospital and received at least two antibiot-
ic doses on those days. Pre/post-culture and susceptibility 
results was taken into account. A total of 46 prescriptions 
were tracked over the two-week period. 95.7% (44/46) 
of cases were deemed to have an appropriate follow-up 
measure. In fact, antibiotics were appropriately stream-
lined or discontinued after culture results came out or 
after the patients’ clinical improvement. Also, antibiotics 
were reasonably escalated for broader-spectrum empir-
ic antibacterial coverage or upon clinical deterioration. 
Only two inappropriate measures were reported where 
an antibiotic was continued or switched to another anti-
biotic with no clear indication or rationale. Table 2 sum-
marizes the appropriateness of the measures assessed 
during the follow-up period.
Table 1 Usage of antibiotics by indication
Indication* N (%) PPS1 PPS2 PPS3 PPS4 PPS5 PPS6
HEENT infection 2 (5.1%) 2 (5.4%) 2 (5.9%) 2 (5.3%) 2 (5.3%) 0 (0.0%)
SSS infection 1 (2.6%) 2 (5.4%) 4 (12.0%) 6 (16.0%) 6 (16.0%) 5 (15.0%)
CAP 1 (2.6%) 3 (8.1%) 1 (2.9%) 2 (5.3%) 2 (5.3%) 0 (0.0%)
HAP 2 (5.1%) 2 (5.4%) 1 (2.9%) 1 (2.6%) 1 (2.6%) 2 (6.1%)
PJP prophylaxis 3 (7.7%) 3 (8.1%) 4 (12.0%) 3 (7.9%) 3 (7.9%) 3 (9.1%)
GI infection 6 (15.0%) 5 (14.0%) 6 (18.0%) 6 (16.0%) 3 (7.9%) 3 (9.1%)
UT infection (complicated/uncomplicated cystitis/
catheter-acquired)
2 (5.1%) 2 (5.4%) 1 (2.9%) 1 (2.6%) 1 (2.6%) 2 (6.1%)
Blood infection (bacteremia) 8 (21.0%) 6 (16.0%) 5 (15.0%) 5 (13.0%) 4 (11.0%) 4 (12.0%)
Febrile neutropenia 8 (21.0%) 7 (19.0%) 8 (24.0%) 8 (21.0%) 7 (18.0%) 7 (21.0%)
Undefined/unknown 6 (15.0%) 5 (14.0%) 2 (5.9%) 4 (11.0%) 9 (24.0%) 7 (21.0%)
Total 39 37 34 38 38 33
*HEENT: head-eye-ear-nose-throat; SSS: skin and skin structure; CAP: community-acquired pneumonia; HAP: hospital-acquired pneumonia; PJP: Pneumocystis Jirovecii Pneumonia; GI: 
gastrointestinal; UT: urinary tract
Table 2 Prospective sub-analysis with follow up based on pre/post culture and susceptibility results
Measure N=cases Appropriateness
Yes No
Culture results positive targeting specific organism (whether 
sensitivity results are available or not)
14 14 0
Culture results pending or negative; antibiotic escalated/de-
escalated after clinical improvement/deterioration or hemodynamic 
instability
8 8 0
Culture results negative or clinical improvement; antibiotic 
discontinued
5 5 0
Antibiotic switch from IV to PO 1 1 0
Patient discharged; antibiotic to be continued at home as per 
documentation in medical chart
2 2 0
Antibiotic course completed based on previous sensitivity results or 
clear indication; patient discharged
10 10 0
Antibiotic continued with no alteration in regimen 4 4 0
Antibiotic continued or antimicrobial switching with no clear 
indication or rationale
2 0 2
Total N=46 95.7% 4.3%
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Phase 2: Feedback using an educational 
intervention
Several recommendations and targets for improvement 
in antibiotic use and prescribing behaviours emerged af-
ter analysing the results of phase 1 of our study. The main 
focus was on proper documentation in electronic health 
records, which helps improve collaboration between 
healthcare practitioners. Making such information ac-
cessible will further help ensure that antibiotics are used 
properly, modified as needed, and discontinued in a time-
ly manner. In fact, we put emphasis on the appropriate 
documentation of: indication of the antibiotic based on 
local prescribing policies or international guidelines 
(whenever it is recommended to start or continue an anti-
biotic); rationale behind not adhering to guidelines when 
applicable; intended duration of treatment course (auto-
matic stop order in CERNER® vs. actual intended dura-
tion); indication for prophylaxis; and the reason behind 
stopping, discontinuing, changing, or adjusting a current 
antibiotic based on culture and sensitivity results or pa-
tient’s actual condition. In order to address the aforemen-
tioned recommendations, an on-spot educational inter-
vention was developed.
Phase 3: Tracking changes and outcome 
measures
Sixty-four medical records were assessed for inclusion 
in the repeated audit. Twenty-four records were only re-
viewed as patients in those records were receiving at least 
one antibiotic on the day of the study audit. Documenta-
tion in electronic health records was sub-optimal. In 60% 
of the cases where there was proper documentation, the 
rationale behind adjusting a treatment regimen based on 
sensitivity results, or even stopping an antibiotic because 
of no clear indication was documented by clinical phar-
macists. Table 3 summarizes the results of phase 3.
Table 3 PDSA tool for the test of change
Aim: To further improve patient outcomes and optimize healthcare
• First test of change: To expand the current ASP at NCCCR to include educational components to determine the best ways to address gaps and 
barriers to judicious antibiotic use (in particular proper documentation in healthcare records)
• Person responsible: Research team
• When to be done: After briefing on the results of phases 1 and 2 during medical rounds
• Where to be done: On-spot educational intervention at NCCCR during medical rounds
Plan:
• Tasks needed to set up this test of change: Repeat an antibiotic audit to 
be compared with results obtained from the pre-intervention phase
• Person responsible: Research team
• When to be done: After the educational intervention
• Where to be done: At NCCCR
• Predict what will happen when the test is carried out: Documentation 
will improve
• Measures to determine if prediction succeeds: Analyzing data using 
descriptive statistic
Do: What actually happened when we ran the test:
• Most practitioners were receptive to feedback and were keen to 
know about the results of the first phase of our study
• Some practitioners were conservative regarding the results
• Practitioners were willing to improve documentation in healthcare 
records
Study: Describe the measured results and how they compared to the 
predictions:
Phase 3: Tracking changes and outcome measures*
*Please refer to the results section
Phase 4: Qualitative thematic analysis
A. Facilitators and barriers for appropriate antibiotic prescribing 
and use
• Several components as perceived by the pharmacists interviewed 
served both as facilitators and barriers; These included: collaboration 
and communication among multidisciplinary teams, adherence and 
compliance to policies and guidelines
• An important facilitator agreed upon all pharmacist interviewed was 
the interventions done by them
• Another barrier discussed relates to some electronic system errors
B. Strategies to overcome barriers as recommended by pharmacists
• Educational sessions and morning reports to highlight upon 
continuous improvements in antibiotics’ use and the benefits of 
consulting the AMS team
• Proper communication among multidisciplinary teams and healthcare 
providers
• Implementation of an official AMS policy to be adhered to
• Adherence to pre-approved local antibiotic policies and guidelines
• Having alternative antibiotic options in instances of drug shortages
• Online AMS training courses for involved healthcare members
• Campaigns to raise awareness regarding proper antibiotic prescribing 
and AMS
Act: Describe what modifications to the plan will be made for 
the next cycle from what you learned:
Targets for improvement
• The educational component as part of enhancing ASPs had to be 
assessed from the pharmacists’ perspectives
• All pharmacists agreed that educational sessions and awareness 
campaigns are necessary and shall involve all multidisciplinary 
teams to be conducted by AMS experts on a regular basis 
regarding antibiotic use and prescribing in hospital settings
• All pharmacists thought that focus-group educational sessions 
are more useful than on-spot educational interventions during 
multidisciplinary rounds as teams change on a regular basis and it 
is better to educate all groups at once
• All pharmacists thought that this can be arranged during morning 
reports or by invitation to a private educational session
• All pharmacists do believe that the impact of education to 
overcome barriers takes time and changes to be seen and achieved 
require rigorous efforts from all healthcare members of the 
multidisciplinary teams
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Phase 4: Qualitative thematic analysis
A total of three pharmacists who witnessed the educa-
tional intervention participated in the semi-structured 
interviewing process. All pharmacists were females and 
practice at NCCCR as members of infectious diseases, 
haematology and oncology multidisciplinary teams. Two 
major themes relating to AMS were identified through-
out the interviews: facilitators and barriers. Recommen-
dations to overcome perceived barriers were also inter-
preted as a sub-theme. Table 4 summarizes the results of 
phase 4.
Discussion
The results of our PPSs showed some improvement in 
AMS practices compared to a previous study (19), which 
signals a culture of AMS may be developing at our insti-
tution. However, a gap was exposed in terms of the docu-
mentation available for clear understanding of antibiotic 
prescribing practices. These results are important, as our 
institution recently switched to an electronic healthcare 
record system. As documentation practices differ from 
previous handwritten notes in medical charts, our re-
sults and interpretations are likely very relevant to other 
centers undergoing similar changes.
While documentation emerged as the area with the 
most room for improvement in our study, its implications 
are controversial. Also, we cannot directly judge that 
62.5% of cases had proper documentation because of our 
educational intervention. This might be possibly due to 
the Hawthorne effect (26). The importance of this issue 
is still an area of debate, especially that there is no well-
established evidence in primary literature that requires 
clinical practitioners to document their rationale behind 
adhering or not to widely adopted clinical practice 
guidelines (27). However, best practices should advocate 
for detailed documentation in the patient medical file. By 
doing so, decision-making becomes transparent and can 
be followed and understood throughout transition points 
in care and also transition of prescribers.
Another important finding emerged from our 
follow-up period that occurred immediately after the 
PPSs. Specifically, clinical pharmacists documented 
the rationale for the majority of documented antibiotic 
therapy decisions and interventions. Clinical pharmacists, 
as members of the multidisciplinary team, are essential 
leaders of antimicrobial stewardship programmes due 
to their expertise in drug therapy, and influencing the 
antibiotic misuse within hospital settings (28–30). Our 
results support their role on AMS services and specifically 
support advanced roles that include documentation in the 
patient healthcare record. As such, team communication 
can be facilitated and seamless care will be ensured.
The interventional portion of our study aligns with 
research from other centres. Previous studies carried 
out in the United States of America, Canada, and Europe 
showed the importance of antimicrobial stewardship 
quality improvement tools (such as the PDSA cycles-
based educational interventions) in increasing rates 
of appropriate antibiotic use and the compliance with 
antibiotic prescribing policies and guidelines (31–33). We 
attempted to use this model to improve documentation 
practices. The educational messages were received 
positively yet impacts on practice are still unclear. 
Achievement of practice change can be very difficult, 
especially with rotational staff and frequent addition 
of medical residents and fellows to multidisciplinary 
teams. Therefore, it is likely that repeated educational 
interventions might be required to promote a culture of 
change and embed good documentation habits within 
the practice culture.
The final analysis of facilitators and barriers can 
help us learn from this experience and provide insight 
for other institutions attempting to implement similar 
interventions. First, communication was identified as 
both a facilitator and a barrier. As all education is based on 
communication, those completing the intervention must 
be good communicators and have experience discussing 
clinical practices with multidisciplinary teams. Secondly, 
clinical pharmacists believed that clinical pharmacist 
interventions are well received and that these team 
members can promote proper use of antibiotics. Thirdly, 
the use of an electronic health system with automatic 
prescription durations and renewals was seen as a 
barrier to AMS. This point stresses the need for better 
documentation of therapy plans (including intended 
duration of therapy), in order to optimize practices at 
transition points in care. By considering these three key 
points, it is likely that uptake of AMS interventions can 
be increased.
Several limitations should be highlighted upon in 
our study. First, all patients audited in this study had a 
primary diagnosis of cancer, an immunocompromised 
condition. Thus, utilization of antibiotics administered in 
different populations cannot be generalized and does not 
reflect all antibiotic-prescribing behaviours throughout 
Table 4 Documentation in healthcare records (indication, duration of therapy, antibiotic treatment plan/change rationale) post 
the educational intervention
Documentation just for clinical indication N=5 (20.8%)
No documentation N=4 (16.7%)
Complete documentation
• Due to intervention made by clinical pharmacist
• Documentation by physician
N=15 (62.5%)
• N=6 (40.0%)
• N=9 (60.0%)
Total N=24 (100%)
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Qatar. Secondly, it was a single centre study but it is likely 
that the interpretations of our data are relevant to other 
centres. Lastly, results were descriptive in nature due 
to the challenges identified in comparing practices that 
occurred before and after our intervention. Specifically, 
we could not rule out a high risk of confounding if 
statistical comparisons were made. However, the 
descriptive snapshots provide rich data that allows for 
great insight into AMS implementation within our 
center.
Conclusions
Our findings show that antimicrobial stewardship meas-
ures have slightly improved over the last three years at 
our institution. However, clinicians are still not follow-
ing prescribing guidelines at all times. Also, our findings 
expose a gap that clinicians are not consistently doc-
umenting the rationale for the use of antibiotics in the 
medical records and that educational interventions could 
be considered as an interventional strategy for future 
improvement. We recommend open forum discussions 
and weekly review meetings to address malpractice with 
continuous efforts to improve documentation, in order 
to facilitate communication among healthcare team 
members. Facilitators to this practice change can include 
improved team communication and inclusion of clinical 
pharmacists on multidisciplinary teams. Our results also 
suggest that practice changes take time and cannot be 
expected after one educational intervention. Therefore, 
educational programs should be longitudinal, repetitive, 
and based on specific individual and/or institutional ob-
served behaviors. Future studies should be designed to 
assess such programs and the ability of ASPs to create a 
culture of continuous quality improvement.
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Implications en matière de pratiques de prescription suite à une intervention de 
gestion des antimicrobiens dans un hôpital universitaire de soins tertiaires au Qatar
Résumé
Contexte : Le mauvais usage des antibiotiques constitue un problème de santé publique à l’échelle mondiale ; il est 
associé à une hausse de la morbidité, à un allongement du temps d’hospitalisation, à une augmentation de la mortalité et 
des coûts des soins de santé, et surtout à la résistance aux antibiotiques.
Objectifs : L’objectif de la présente étude était de mesurer la conformité des prescriptions d’antibiotiques avec les 
directives nationales, d’évaluer la façon dont les interventions éducatives peuvent être utilisées au mieux pour avoir un 
impact et combler les lacunes en vue d’une utilisation optimale des antibiotiques, et d’identifier les facteurs favorables et 
les barrières à la mise en œuvre de programmes de gestion des antimicrobiens au Qatar.
Méthodes : Six vérifications de référence transversales de la prescription d’antibiotiques ont été conduites sur une 
période de deux semaines dans un hôpital universitaire de soins tertiaires. Nous avons ensuite procédé à une sous-
analyse des prescriptions ainsi qu’à un suivi des comportements de prescription. Une intervention éducative reposant sur 
la méthode PDCA (planifier–développer–contrôler–ajuster) a été mise en œuvre afin de combler les lacunes identifiées. 
Une deuxième série de vérifications a été conduite afin d’évaluer l’impact du changement. Enfin, des entretiens ont été 
menés afin de reconnaître les facteurs favorables et les barrières perçus pour la mise en œuvre de programmes de gestion 
des antimicrobiens, d’identifier des stratégies pour faire tomber ces barrières, et d’évaluer l’efficacité des interventions 
éducatives.
Résultats : La neutropénie fébrile était l’indication la plus courante pour la prescription d’antibiotiques (20,7 %). La classe 
d’antibiotiques utilisée le plus fréquemment était celle des carbapénèmes (21,4 %). Soixante pour cent des prescriptions 
étaient conformes aux lignes directrices. Les raisons qui justifiant le non respect de ces dernières n’étaient pas documentées 
dans 37,2 % des cas. Notre intervention se concentrait également sur la documentation sous-optimale des comportements 
en matière de prescription dans les dossiers médicaux. Une légère amélioration a été notée dans ce domaine lors de 
l’intervention post-vérification. Les facteurs favorables et les barrières incluaient : la collaboration et la communication 
entre les équipes, la conformité avec les lignes directrices, les interventions documentées par les pharmaciens cliniciens, 
et les erreurs de systèmes électroniques.
Conclusions : Une communication efficace, une documentation constante des comportements en matière de 
prescription  dans les dossiers médicaux, et la formation continue des personnels encouragent une prescription rationnelle 
des antibiotiques et renforcent les programmes de gestion des antimicrobiens.
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رطق ،ةيثلاثلا ةياعرلل ةيميلعتلا تايفشتسلما دحأ في تابوركيلما تاداضلم يرادإ لخدتل ةسرمالما تايعادت
يبليو لياك ،يزازعلا نييرش ،نماثع ةشئاع ،يرشبلا ةورم ،ركباب ءايلع ،صرن دايز
ةصلالخا
 ،ةافولاو ،ىفشتسلما في ةماقلإا ةدم لوطو ،ةضارلما ةدايزب طبترتو ،ةماعلا ةحصلا هجاوت ةيلماع ةلكشم ةيويلحا تاداضلما مادختسا ءوس ُّدَعُي :ةيفللخا
.صوصلخا هجو لىع ةيويلحا تاداضلما ةمواقمو ،ةيحصلا ةياعرلا فيلاكتو
 رثأ  ثادحلإ ةيعوتلا  تلاخدتل  مادختسا لضفأ مييقتو ،ةينطولا  ةيهيجوتلا  ئدابملل  ةيويلحا تاداضلما  فصو لاثتما  مييقت  لىإ  انفده :فادهلأا
 تابوركيلما تاداضلم يرادإ جمانرب ذيفنت مامأ قئاوعلاو ةسريلما لماوعلا ديدتحو ،ةيويلحا تاداضملل لثملأا مادختسلاا في تاوجفلا بأرو ظوحلم
.رطق في
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 رايتخا ءارو يرهولجا ببسلا قثوُي لمو .ةيهيجوتلا ئدابلما عم ةيبطلا تافصولا نم ةئالماب نوتس قفاوتيو .)%21.4( ةيويلحا مينيبابراك تاداضم يه
 تحضوأو .انب صالخا لخدتلا للاخ نم تلاجسلا في لياثلما نود قيثوتلا فادهتسا متو .تلاالحا نم %37.2 في ةيهيجوتلا ئدابلماب مازتللاا مدع
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.نيوتركللإا ماظنلا ءاطخأو ،ينيريسرلا ةلدايصلا لَبِق نم ةقثولما تلاخدتلاو ،ةيهيجوتلا
 لوقعم  وحن  لىع  ةيويلحا  تاداضلما  فصو  زيزعت  في  ةرركتلما  ةيعوتلاو  ،تلاجسلا  في  رمتسلما  قيثوتلاو  ،لاّعفلا  لصاوتلا  دعاسي  :تاجاتنتسلاا
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